Julien Bradley is the founder of RedShift BioAnalytics. RedShift BioAnalytics has raised $18M in total funding. Latest round: Series D.
Julien Bradley was appointed CEO of RedShift BioAnalytics in 2020. He leads the commercial expansion of the company's infrared spectroscopy tools used in biopharmaceutical companies. This appointment followed the closure of an $18 million Series D funding round.
Full founder directory · Investor directory · Company funding database · Fundraising library